drugset / Trial / NCT01105533
A Dose Finding Study Of A New Medication, PF-00337210 That Will Possibly Decrease Blood Supply To Tumors
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study will test a new cancer medication to determine if this medication will block blood supply to a tumor and decrease growth of a tumor. This study will also define the safety profile and define the safest dose of this new medication for people who have cancer.
Timeline
- Start
- 2006-05
- Primary completion
- 2010-10
- Completion
- 2011-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-00337210 | Small molecule | 0.67 mg | — |
| Subject | PF-00337210 | Small molecule | 1 mg | — |
| Subject | PF-00337210 | Small molecule | 2 mg | — |
| Subject | PF-00337210 | Small molecule | 4 mg | — |
| Subject | PF-00337210 | Small molecule | 6 mg | — |
| Subject | PF-00337210 | Small molecule | 8 mg | — |
| Subject | PF-00337210 | Small molecule | 9 mg | — |